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The renal lesions that develop in neonatal mice during
angiotensin inhibition mimic obstructive nephropathy
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The renal lesions that develop in neonatal mice during angio- Considerable evidence has amassed to suggest that
tensin inhibition mimic obstructive nephropathy. angiotensin II plays an important regulatory role in the
Background. Inhibition of angiotensin action, pharmacolog- development of the kidney. Indeed, renin and angioten-ically or genetically, during the neonatal period leads to renal
sin are up-regulated in the kidney during the perinatalanomalies involving hypoplastic papilla and dilated calyx. Re-
period [1–4], and pharmacological blockade of the renin-cently, we documented that angiotensinogen (Agt 2/2) or
angiotensin type 1 receptor nullizygotes (Agtr1 2/2) do not angiotensin system in neonatal rats induces gross abnor-
develop renal pelvis nor ureteral peristaltic movement, both malities in the structure and function of the kidney [5, 6].
of which are essential for isolating the kidney from the high Moreover, recent gene targeting studies revealed thatdownstream ureteral pressure. We therefore examined whether
mice lacking angiotensinogen [7–9], angiotensin-convert-these renal anomalies could be characterized as “obstructive”
ing enzyme (ACE) [10–12], or type 1 receptor [13] de-nephropathy.
Methods. Agtr1 2/2 neonatal mice were compared with velop major abnormalities in renal morphogenesis, which
wild-type neonates, the latter subjected to surgical complete become evident shortly after birth. However, the mecha-
unilateral ureteral ligation (UUO), by analyzing morphometri- nistic explanation has not been provided linking the lack
cal, immunohistochemical, and molecular indices. Agtr1 2/2
of angiotensin action and the abnormal renal develop-mice were also subjected to a complete UUO and were com-
ment.pared with wild-type UUO mice by quantitative analysis. To
assess the function of the urinary tract, baseline pelvic and The renal pelvis, an organ unique to mammals, consists
ureteral pressures were measured. of a smooth muscle layer extending from the renal paren-
Results. The structural anomalies were qualitatively indistin- chyma to the downstream ureter. The pelvis develops
guishable between the Agtr1 2/2 without surgical obstruction
immediately after birth when the renal system faces dualversus the wild type with complete UUO. Thus, in both kidneys,
challenges of achieving some 50-fold increase in urinethe calyx was enlarged, whereas the papilla was atrophic; tubu-
lointerstitial cells underwent proliferation and also apoptosis. production to eliminate nitrogenous wastes entirely
Both were also characterized by interstitial macrophage infil- through the kidney [14] and, at the same time, of estab-
tration and fibrosis, and within the local lesion, transforming lishing the mechanism by which the high urine output is
growth factor-b1, platelet-derived growth factor-A, and insu-
matched by efficient removal of urine from the kidney.lin-like growth factor-1 were up-regulated, whereas epidermal
Under the control of its pacemaker cells, the pelvis initi-growth factor was down-regulated. Moreover, quantitative dif-
ferences that exist between mutant kidneys without surgical ates peristaltic movements to transfer urine rapidly from
obstruction and wild-type kidneys with surgical UUO were the kidney to the ureter [15, 16]. Of note, angiotensin
abolished when both underwent the same complete surgical type 1 receptor is intensely expressed along the pelvic
UUO. The hydraulic baseline pressure was always lower in
smooth muscle [4, 17], and angiotensin can stimulatethe pelvis than that in the ureter in the wild type, whereas this
contraction of the pelvic smooth muscle in in vitro set-pressure gradient was reversed in the mutant.
Conclusion. The abnormal kidney structure that develops in tings [18].
neonates during angiotensin inhibition is attributed largely to In a recent study, we found that mice lacking either
“functional obstruction” of the urinary tract caused by the angiotensinogen (Agt 2/2) or both angiotensin type 1
defective development of peristaltic machinery.
A and 1B receptors (Agtr1 2/2) fail to develop a renal
pelvis or ureteral peristaltic movement [4]. The ability
of angiotensin to induce the pelvis directly was demon-Key words: gene targeting, unilateral ureteral obstruction, angiotensin
converting enzyme inhibitor, renal pelvis, ureter. strated in an organ culture system in which treatment
with angiotensin induced the characteristic smooth muscleReceived for publication August 21, 1998
layer, which is missing in homozygous mutants. We there-and in revised form December 8, 1998
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velop shortly after birth in animals, which are subjected 1999 by the International Society of Nephrology
1683
Miyazaki et al: Renal lesions in neonates1684
to pharmacological or genetic inhibition of angiotensin saline for 5 (N 5 5) or 21 days (N 5 5). These mice
were then analyzed for gross morphology of the renalaction, specifically atrophic papilla and dilated calyx, are
equivalent to an obstructive nephropathy in nature. pelvis and renal histology as specified later in this article.
In this study, we measured several structural and mo-
Assessment of renal pelvic and ureteral pressurelecular indices in Agtr1 2/2 kidneys and found that
morphometrically, immunohistochemically, molecularly, Mice were anesthetized with an intraperitoneal injec-
tion of 60 mg/kg body wt sodium pentobarbital. Follow-and otherwise, the nature of the renal parenchymal dam-
age of Agtr1 2/2 mice is qualitatively indistinguishable ing tracheostomy, a polyethylene catheter (PE-10) was
placed into the right jugular vein for continuous infusionfrom that of wild-type mice that have been subjected to
a complete surgical unilateral ureteral ligation (UUO). of saline (2 ml/hr). After a midline incision of the abdo-
men, the dome of the bladder was punctured with a 22Moreover, the quantitative difference that existed be-
tween Agtr1 2/2 mice without surgical obstruction and gauge needle to allow free urine outflow. The fat pad
surrounding the kidney was anchored in order to immo-wild-type mice with UUO was essentially abolished when
both had undergone the same complete surgical UUO, bilize the left renal pelvis, and the fat pad surrounding
the pelvis was gently removed. The hydraulic pressureindicating that the abnormal kidney structure of angio-
tensin type 1 receptor null mutants is attributed largely within the urinary tract was recorded with a continuous
recording, servo-null micropipette transducer systemto “functional obstruction” of the urinary tract caused
by the defective development of peristaltic machinery. (model 4A; Instrumentation for Physiology and Medi-
cine, San Diego, CA, USA) as described previously [19].
METHODS Histological study
Animals Kidneys were fixed with 4% buffered paraformalde-
hyde for four hours, dehydrated, embedded in paraffin,To obtain pups lacking both angiotensin type 1A
(AT1A) and type 1B (AT1B) receptors, double hetero- sectioned at 4 mm, and subjected to the following histo-
logical examinations.zygous null mutants (Agtr1a 1/2, Agtr1b 1/2) on a
mixed 129/Ola and C57BL/6 genetic background were Immunohistochemistry. Rat antimouse F4/80 (1:300 di-
lution; Selotec, Oxford, UK), mouse antihuman a-smoothinterbred as described previously [4, 13]. The offspring
that carried the genotype 1/1 or Agtr1a 2/2 and Agtr1b muscle actin (SMA; Dako, Carpinteria, CA, USA), goat
antihuman insulin-like growth factor (IGF1; 1:200 dilu-2/2 (abbreviated as Agtr1 2/2), which had neither 1A
nor AT1B receptors, were used in this study. The Agtr1 tion; R&D System, Minneapolis, MN, USA), and rabbit
antimouse epidermal growth factor (EGF; 1:4000 dilu-genotype was determined by Southern blot analysis on
DNA isolated from tail biopsies. tion; Sigma, St. Louis, MO, USA) were used as primary
antibodies.
Surgical preparation of unilateral ureteral obstruction The ABC method was applied for immunostaining
with F4/80, IGF1, or EGF antibody. After quenchingSome animals were subjected to experimental ureteral
obstruction. Under anesthesia by intraperitoneal injec- with 3% hydrogen peroxide in methanol for 10 minutes
and preincubation in blocking solution of Vectastainttion of sodium pentobarbital (60 mg/kg body wt), the
left ureters of 16-day-old mice were ligated with 6-0 silk ABC kit (Vector, Burlingame, CA, USA) for two hours,
sections were incubated with primary antibody for 16and cut between the two ligated points, whereas in sham
operation, the ureter was identified and left undisturbed. hours at 48C. After washing with phosphate-buffered
saline (PBS), the sections were incubated with biotinyl-After the pups recovered from anesthesia, they were
returned to their mother. At five days after surgery, ated second antibody (Vector) for 30 minutes and then
incubated in avidin-biotin complex peroxidase solutionobstructed kidneys were harvested and subjected to the
analyses specified later here (N 5 6, Agtr1 1/1 with (Vector) for one hour at room temperature. Develop-
ment was accomplished with incubation in peroxidasesham operation, N 5 6 for Agtr1 2/2 with sham opera-
tion, N 5 6 for Agtr1 1/1 with UUO, and N 5 5 for substrate (Research Genetics, Huntsville, AL, USA) for
three to five minutes at room temperature.Agtr1 2/2 with UUO).
For immunostaining with a-SMA antibody, the sec-
Inhibition of angiotensin-converting enzyme during tions were incubated with primary antibody conjugated
the neonatal period with horseradish peroxidase for one hour at room tem-
perature and developed in peroxidase substrate (Re-Wild-type mice were injected subcutaneously with
ACE inhibitor (imidapril, 20 mg/kg/day) in a volume of search Genetics), following the manufacturer’s protocol.
Morphometric analyses of the papilla to calyx ratio,10 ml/g. Injections started at the day of birth and contin-
ued until 5 (N 5 5) or 21 days of age (N 5 5). As a proliferating cells, apoptotic cells, macrophage infiltra-
tion, and a-smooth muscle actin expression. To measurecontrol, mice were injected with an equal volume of
Miyazaki et al: Renal lesions in neonates 1685
the papilla to calyx ratio in the kidney specimen, three 0 represents no expression, 1 represents mild expression,
2 represents moderate expression, and 3 represents se-nonadjacent coronal sections of the kidneys at the level
of the renal hilum were traced with the aid of camera vere expression, according to the method of Kaneto,
Morrissey and Klahr [21]. In each section, the score waslucida attachment and scanned with JX-330M scanner
(Sharp Co., Osaka, Japan). The area of the papilla or counted in eight random fields under high magnification,
and the score was averaged for each field.maximum calyceal space was quantitated using the Na-
tional Institutes of Health Image program. The percent- In situ hybridization for transforming growth factor-b1
and platelet-derived growth factor-A. Mouse Sma I-Sma Iages of the papillary area to the papillary plus caliceal
area were averaged for each kidney, and then the values fragment of TGF-b1 cDNA clone [7, 22] and Pst I-EcoR I
fragment of PDGF-A cDNA clone [7, 23] were used asfrom six kidneys were further averaged.
The bromodeoxyuridine (BrdU) labeling method was templates to synthesize 35S-labeled cRNA antisense and
sense probe by in vitro transcription kit (Ambion, Aus-used to identify proliferating cells. One day before sacri-
fice, mice were given three intraperitoneal injections of tin, TX, USA) following the manufacturer’s protocol.
These probes cover 0.97 kb (421 to 1395 bp) and 0.56BrdU (0.1 mg/g body wt; Boehringer Mannheim, Mann-
heim, Germany) at nine-hour intervals. Two hours after kb (345 to 906 bp), respectively, of mouse transforming
growth factor-b1 (TGF-b1) and platelet-derived growththe last injection, kidneys were removed and processed
as described earlier here. Immunostaining for BrdU was factor-A (PDGF-A) cDNA.
The protocol for in situ hybridization was a slight mod-performed with anti-BrdU antibody (Calbiochem, Cam-
bridge, MA, USA) following the manufacturer’s protocol. ification of one described previously [7]. Sections were
refixed in 4% paraformaldehyde (PFA) for 20 minutes,For individual kidneys, eight nonoverlapping fields within
either the cortex or medulla were examined under high washed in PBS, and then treated with 2 mg/ml proteinase
K for five minutes. Subsequently, sections were twicemagnification (3400), and the number of BrdU-positive
nuclei was averaged for each field (nuclei/4003 field), acetylated with 0.4% (vol/vol) acetic anhydride in 0.1 m
triethanolamine for 10 minutes. After rinsing in PBS,and the values from six kidneys were then averaged.
The terminal deoxy transferase uridine triphosphate sections were dehydrated through graded alcohols and
air dried. Sections were covered with 100 ml of hybridiza-nick end-labeling (TUNEL) method was employed to de-
tect apoptotic cells according to the protocol that Gavrieli, tion mixture containing 35S-labeled cRNA probe (2 3
104 cpm/ml), 50% deionized formamide, 10% dextranSherman and Ben-Sasson described [20]. After treatment
with 2.5 mg/ml of proteinase K (Sigma) for 10 minutes, sulfate, 8 mm dithiothreitol (DTT), 0.2 mg/ml tRNA,
0.02% Ficoll, and 0.02% bovine serum albumin and weresections were incubated with 0.01 nmol/ml of digoxi-
genin-conjugated dUTP (Boehringer Mannheim) and 0.25 then incubated overnight at 508C in a sealed, humidified
container. After hybridization, the slides were washedU/ml terminal transferase (Boehringer Mannheim) for
16 hours at 48C. The slides were washed extensively with in 50% formamide, 2 3 standard saline citrate (SSC),
and 100 mm DTT at 658C for 20 minutes and were treatedwater and a solution containing 0.1 m maleic acid and
0.15 m NaCl (pH 7.5). A digoxigenin antibody alkaline with 20 mg/ml RNase A at 378C for 30 minutes. Sections
were washed in 2 3 SSC, followed by 0.1 3 SSC atphosphatase-conjugated Fab fragment (Boehringer Mann-
heim) was used for detection of the digoxigenin incorpo- 658C, dehydrated through graded alcohols with 0.3 m
ammonium acetate, and air dried. They were dipped inrated into the DNA. Rat thymus tissues harvested after
irradiation were used for positive control. The number photographic emulsion (Ilford K2 emulsion; Ilford Ltd.,
Essex, UK), diluted in 2% glycerol solution, air dried,of TUNEL-positive cells was examined in the cortical
or medullary region, normalized by the area measured and exposed at 48C for 10 to 14 days. After development
with D-19 developer, the slides were counterstained withplanimetrically using the Micro-Plan II image analysis
system, and expressed as TUNEL-positive cells/mm2. 0.1% toluidine blue.
Macrophage infiltration was determined by the num-
Northern blot analyses for transforming growthber of cells within the cortex or medulla, which were
factor-b1, platelet-derived growth factor-A, epidermalstained positively with F4/80 antibody. For individual
growth factor, and insulin-like growth factor 1 mRNAkidneys, eight nonoverlapping fields within either the
cortex or medulla were examined under high magnifica- The cDNA probes for mouse TGF-b1, PDGF-A, and
EGF were the 0.97 kb Sma I-Sma I fragment [22], thetion (3400), and the numbers of positive cells were aver-
aged for each field (nuclei/4003 field), and the values 0.56 kb Pst I-EcoR I fragment [23], and 0.78 kb Apa
I-Spe I fragment of EGF cDNA [24], respectively. Thefrom six kidneys were then averaged.
Expression of a-SMA in the interstitium was assessed cDNA probe for mouse IGF1 was synthesized and ampli-
fied from mouse kidney total RNA using oligonucleotidesemiquantitatively by immunoreactivity for a-SMA. The
expression score from 0 to 3 was based on the intensity primers as follows: 59 primer, 59-AGCTCCACCACAG
CTGGACCA-39: 39 primer, 59-ACGGATAGAGCGGGand distribution of a-SMA immunoreactivity, in which
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CTGCTTTTGAT-39 [25]. The amplified fragment was
subcloned into PCRtII-TOPO (Invitrogen, Carlsbad, CA,
USA), and the specific insert was used as the IGF1 probe.
Twenty micrograms of whole kidney RNAs were elec-
trophoresed in 1% agarose, 2.2 m formaldehyde, and
MOPS buffer gel, transferred to a nylon membrane (Hy-
bond-N1; Amersham Life Science Inc., Arlington
Heights, IL, USA) and hybridized with 32P-labeled
probe. Following hybridization, the membranes were
washed in 2 3 SSC in 0.1% sodium dodecyl sulfate (SDS)
for 10 minutes at room temperature twice and then 0.2 3
SSC in 0.1% SDS for 15 minutes at 658C twice. The
membrane was rehybridized with a human glyceralde-
hyde 3-phosphate dehydrogenase (GAPDH) cDNA
probe (Clontech, Palo Alto, CA, USA) as a control for
RNA loading. The hybridization signal of each mRNA
was detected by autoradiography and scanned with JX-
330M scanner (Sharp Co.), and semiquantitated using
Fig. 1. Renal pelvic and ureteral pressure in Agtr1 1/1 and Agtr1 2/2.National Institutes of Health Image program.
Intrarenal pelvic and intraureteral pressures were monitored in the
same mice by the servo-nulling micropuncture method. In all of theStatistical analysis wild-type mice examined (N 5 4), baseline pressure in the pelvis was
lower than that in the downstream ureter, whereas this baseline pressureData are presented as means 6 se. Statistical analysis
gradient was reversed in Agtr1 2/2 mice (N 5 4).was performed using analysis of variance followed by
Bonferroni test for multiple comparisons.
Examination for cell proliferation, apoptotic cells,
RESULTS macrophage infiltration, and a-smooth muscle actin
Measurement of pressure within the pelvis and ureter expression in the interstitium
Previously, we measured peristaltic pressure within Bromodeoxyuridine-positive nuclei are observed
the pelvis of wild-type and Agtr1 2/2 mice and found mainly in tubules and, to a lesser extent, in the intersti-
that in wild-type mice, the renal pelvic pressure exhibits tium in all preparations (Fig. 3). As shown in Figure 4,
slow rhythmic pulsatile changes with constant frequency, for the cortex, a high level of BrdU incorporation is
whereas the regular contraction of the renal pelvis is observed in wild-type kidneys at the age of 21 days, as
absent in mutant mice. This time, we measured the pelvic in the Agtr1 2/2 kidneys (Agtr1 1/1, 94.0 6 9.7/4003
pressure and the downstream ureteral pressure at the field, N 5 6; Agtr1 2/2, 119.6 6 9.2/4003 field, N 5
same time in the same mice (Fig. 1). Although the values 6). By contrast, in the medulla, BrdU-positive cells are
for pelvic and ureteral pressure differ among mice within significantly higher in number in the Agtr1 2/2 kidneys
each group, the baseline pressure is always lower in the (94.2 6 3.2/4003 field, N 5 6) than in wild-type kidneys
pelvis than in the distal ureter in the wild type (on aver- (25.3 6 2.5/4003 field, N 5 6, P , 0.001), and comparable
age by 7.0 6 0.3 mm Hg, N 5 4), whereas this pressure only to wild-type kidneys with surgical UUO (112.5 6
gradient is reversed in mutants (on average by 1.2 6 0.3 3.2/4003 field, N 5 6).
mm Hg, N 5 4; Fig. 1). TUNEL staining revealed that, in the wild type, there
are only few apoptotic cells in the kidney (cortex, 0.3 6
Gross histological examination 0.1/mm2; medulla, 1.0 6 0.3/mm2), whereas in the Agtr1
Evaluation of coronal sections reveals that Agtr1 2/2 2/2, the apoptotic cell number is distinctively increased
kidneys have distinctive pathologic lesions, for example, along the dilated tubules in the cortex and medulla (cortex,
hypoplastic papilla, tubular atrophy and dilation, and 6.5 6 1.2/mm2, P , 0.05; medulla, 10.9 6 1.3/mm2, P ,
interstitial fibrosis, that is, features that are similar to 0.05; Figs. 3 and 4). High-power views of Figure 3 E–G
those in Agtr1 1/1 kidneys with surgical UUO (Fig. 2). were also presented by Miyazaki et al [4]. Surgical com-
Morphometrical analysis shows that the papilla to calyx plete UUO led to increased apoptotic cells in Agtr1 1/1
ratio is significantly lower in Agtr1 2/2 kidneys (Agtr1 kidneys (cortex, 20.5 6 3.7, P , 0.001; medulla, 26.0 6
1/1 kidneys, 84.0 6 1.5%; Agtr1 2/2 kidneys, 54.5 6 2.9/mm2, P , 0.001) in a region similar to Agtr1 2/2
8.2, N 5 6, P , 0.01), although the ratio is higher than kidneys in a degree greater than the latter (P , 0.01).
that in Agtr1 1/1 kidneys with surgical UUO (22.5 6 F4/80-positive cells were present primarily in the renal
interstitium that directly surrounds renal tubules (Fig.2.3%, P , 0.01, N 5 6).
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Fig. 2. Morphology of the kidney of 21-day-old Agtr1 2/2 and Agtr1
1/1 with surgical UUO. Agtr1 1/1 kidneys with (B, F) or without (A,
E) surgical UUO. Agtr1 2/2 with (D, H) or without (C, G) surgical
UUO. Hypoplastic papilla is present in (B–D). Atrophic and dilated
tubules are present in the medulla in Agtr1 2/2 (G, H) and Agtr1 1/1
kidney only with surgical UUO (F). Interstitial fibrosis is also seen
around atrophic tubules. (I) Papilla to caliceal space area ratio is ex-
pressed as mean 6 se. Mild and severe hypoplasia of the papilla are
present in Agtr1 2/2 and Agtr1 1/1 kidney with surgical UUO, respec-
tively. No significant difference is present between Agtr1 2/2 and
Agtr1 1/1 kidneys when both carry complete UUO. *P , 0.01 vs.
unmanipulated Agtr1 1/1 ; †P , 0.01 vs. unmanipulated Agtr1 2/2.
3). The Agtr1 2/2 kidney has a significantly greater both cortex and medulla to levels (cortex, 97.8 6 8.5/
4003 field; medulla, 83.8 6 8.6/4003 field) that are quan-degree of macrophage infiltration (cortex, 77.7 6 5.1/
4003 field; medulla, 74.5 6 9.1/4003 field) than that of titatively similar to those in Agtr1 2/2 kidneys.
Immunoreactivity of a-SMA is present homoge-the wild type (cortex, 26.0 6 4.3/4003 field, P , 0.01;
medulla, 34.5 6 4.0/4003 field, P , 0.01; Fig. 4). Surgical neously in the interstitium that surrounds tubules in the
cortex and intensely in the inner stripe of outer medullaUUO in the wild type increases F4/80-positive cells in
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Fig. 3. Detection of proliferating cells (BrdU-positive cells), apoptotic cells (TUNEL-positive cells), macrophage (F4/80-positive cells) infiltration,
and a-smooth muscle actin (a-SMA) expression. (A, E, I, and M) Unmanipulated Agtr1 1/1 kidneys. (B, F, J, and N) Agtr1 1/1 kidney with
surgical UUO. (C, G, K, and O) Unmanipulated Agtr1 2/2 kidneys, and (D, H, L, and P) Agtr1 2/2 kidneys with surgical UUO. (A–D) BrdU-
positive cells are stained in brown. (E–H) TUNEL-positive cells are stained in deep blue. BrdU- or TUNEL-positive cells are increased in number
along the tubules of Agtr1 2/2 kidneys and Agtr1 1/1 kidneys only with surgical UUO. (I–L) F4/80 positive cells are stained in brown. (M–P)
a-SMA expression is shown in brown. Infiltration of F4/80-positive cells or expression of a-SMA is observed in abundance in the interstitium that
surrounds the tubules of Agtr1 2/2 kidneys and Agtr1 1/1 kidneys with surgical UUO, but not without surgical UUO. There is no qualitative
or quantitative difference between Agtr1 2/2 and Agtr1 1/1 kidneys, both with complete UUO.
of Agtr1 2/2 kidneys (cortex, 0.94 6 0.12/4003 field; revealed that in the wild-type kidneys, surgical UUO
increases a-SMA expression in the interstitium of themedulla, 1.76 6 0.08/4003 field), whereas a-SMA positi-
vity is substantially less in the wild type with intact ureter same regions as Agtr1 2/2 kidneys to levels similar to
Agtr1 2/2 kidneys (cortex, 1.22 6 0.04/4003 field; me-(cortex, 0.21 6 0.03/4003 field, P , 0.001; medulla, 0.53 6
0.04/4003 field, P , 0.001; Figs. 3 and 4). Further analysis dulla, 1.31 6 0.08/4003 field).
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Fig. 4. Quantitative analyses for proliferat-
ing cells, apoptotic cells, macrophage infiltra-
tion, and a-SMA expression. (A) represents
number of BrdU positive nuclei in cortex (h)
or medulla (j). In the medulla, but not in the
cortex, BrdU-positive nuclei are increased in
Agtr1 2/2 kidneys to a level similar to Agtr1
1/1 kidneys with surgical UUO. (B) TUNEL-
positive cells are higher in number in Agtr1
2/2 kidneys than those in unmanipulated
Agtr1 1/1 kidneys in both cortex and medulla,
although lower than those in Agtr1 1/1 kid-
neys with UUO. Macrophage infiltration (C)
and a-SMA expression (D) are higher in Agtr1
2/2 kidneys than those in unmanipulated
Agtr1 1/1 kidneys and comparable to Agtr1
1/1 kidneys with UUO in both cortex and
medulla. Values are expressed as mean 6 se.
*P , 0.01 vs. unmanipulated Agtr1 1/1 ; †P ,
0.05 vs. unmanipulated Agtr1 2/2; #P , 0.05
vs. Agtr1 1/1 kidneys with UUO.
Expression of transforming growth factor-b1, for both TGF-b1 and PDGF-A mRNAs are present in
platelet-derived growth factor, insulin-like growth the areas of interstitial fibrosis that surround dilated tu-
factor 1, and epidermal growth factor bules in Agtr1 2/2 and Agtr1 1/1 kidneys with surgical
UUO (Fig. 6), whereas Agtr1 1/1 kidneys without UUOIt has been shown that surgical UUO alters the expres-
have no appreciable signals for TGF-b1 and weak signalssion of some growth factors in rodents; for example,
for PDGF-A in the papilla. Immunostaining for IGF1TGF-b1 is up-regulated [21, 26], whereas EGF is down-
revealed that IGF1 was weakly positive in the proximalregulated [27]. To ascertain that similar alterations in
tubules within the deep cortex of Agtr1 1/1 kidneysgrowth factor expression take place in Agtr1 2/2 kid-
without UUO, and the IGF1 immunoreactivity was in-neys, TGF-b1, PDGF-A, IGF-1, and EGF expressions
tensified and extended to the superficial cortical area inwere examined by a combination of Northern blot analy-
both Agtr1 2/2 and Agtr1 1/1 kidneys with surgicalsis, in situ hybridization, and immunohistochemistry. As
UUO (Fig. 6). In addition, intense EGF immunoreactiv-shown in Figure 5, Northern blot analysis revealed that
ity is present in the distal tubules of Agtr1 1/1 kidneysin both Agtr1 2/2 and Agtr1 1/1 with surgical UUO,
without UUO, contrasting to the decreased intensity inthe levels of TGF-b1 (Agtr1 2/2, 2.8-fold; Agtr1 1/1
the immunoreactivity in both Agtr1 2/2 and Agtr1 1/1with UUO, 6.9-fold, mean values relative to those of
kidneys with UUO (Fig. 6).Agtr1 1/1 without UUO), PDGF-A (2.3-fold, 3.3-fold),
and IGF-1 mRNAs (1.8-fold, 2.5-fold) are significantly
Examination for Agtr1 2/2 kidney undergoinghigher, and the level of EGF mRNA expression is sig-
complete surgical obstructionnificantly lower (Agtr1 2/2, 0.52; Agtr1 1/1 with UUO,
All of the parameters measured and described earlier0.29) than those of Agtr1 1/1 kidneys without UUO.
In situ hybridization revealed that the specific signals here in Agtr1 2/2 kidneys are qualitatively similar to those
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Fig. 5. Northern blot analyses for expressions of TGF-b1, PDGF-A, IGF1, and EGF mRNA. (A)
Typical hybridization patterns. (B) Densities obtained with the specific probes are standardized by
those with GAPDH probe. In both Agtr1 1/1 kidneys with surgical UUO and Agtr1 2/2
kidneys, TGF-b1, PDGF-A, and IGF1 are up-regulated, whereas EGF is down-regulated. No
significant difference is present in the level of TGF-b1, PDGF-A, and IGF1 mRNA between
Agtr1 2/2 and Agtr1 1/1 kidneys, both with complete UUO. The level of EGF mRNA is
significant lower in Agtr1 2/2 with UUO than that in Agtr1 1/1 with UUO. Values are expressed
as mean 6 se. *P , 0.05 vs. unmanipulated Agtr1 1/1 ; †P , 0.05 vs. unmanipulated Agtr1
2/2; #P , 0.05 vs. Agtr1 1/1 kidneys with UUO.
in Agtr1 1/1 with surgically induced complete UUO. To what higher in the Agtr1 2/2 kidneys with UUO (cortex,
121.2 6 16.0/4003 field; medulla, 133.0 6 10.0/4003 field,test whether the quantitative differences that exist in these
parameters between the two mouse groups are attributed N 5 5) than that in Agtr1 1/1 kidneys with UUO (cor-
tex, 107.7 6 3.6; medulla, 112.5 6 3.2, N 5 6), the differ-merely to the degree of completeness of urinary tract
obstruction and not to a fundamental difference in the ence is not statistically significant. Likewise, the number
of apoptotic cells is similar during UUO in Agtr1 2/2pathophysiology leading to the renal lesions, we surgically
created a complete UUO in Agtr1 2/2 mice and subse- (cortex, 18.4 6 4.6/mm2; medulla, 36.1 6 6.7/mm2, N 5 5)
and Agtr1 1/1 kidneys (cortex, 20.5 6 3.3; medulla,quently repeated assessments for all of these parameters.
Although the levels of BrdU incorporation are some- 26.0 6 2.9, N 5 6; Figs. 3 and 4).
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Fig. 6. In situ hybridization for TGF-b1 and PDGF-A mRNA and immunohistochemistry for IGF1 and EGF. (A, E, I, and M) Unmanipulated
Agtr1 1/1 kidneys. (B, F, J, and N) Agtr1 1/1 kidney with surgical UUO. (C, G, K, and O) Unmanipulated Agtr1 2/2 kidneys, and (D, H, L,
and P) Agtr1 2/2 kidneys with surgical UUO. Signals for TGF-b1 mRNA (A–D) and PDGF-A mRNA (E–H) are shown by dark field photographs
in lower magnifications. Both signals are present in the areas of interstitial fibrosis in Agtr1 2/2 and Agtr1 1/1 kidney with surgical UUO. Note
that PDGF-A mRNA is detected in the papillary region of Agtr1 1/1 kidneys and not of Agtr1 2/2 kidneys. (I–L) Immunoreactive IGF1 is
shown in brown. IGF1 is weakly positive in the proximal tubules of the Agtr1 1/1 kidney without UUO. The immunoreactivity is intensified in
the Agtr1 2/2 and Agtr1 1/1 kidneys with surgical UUO. (M–P) Intense EGF immunoreactivity is present in the distal tubules of the Agtr1 1/1
kidney without UUO. The immunoreactivity decreases in both Agtr1 2/2 and Agtr1 1/1 kidneys with surgical UUO. There is no qualitative or
quantitative difference between Agtr1 2/2 and Agtr1 1/1 kidneys, both with complete UUO, except for PDGF-A expression in the papilla.
With regards to the papilla to calyx ratio, macrophage Agtr1 2/2 and Agtr1 1/1 when both carry complete
UUO (papilla to calyx ratio: Agtr1 2/2, 26.7 6 2.6%;infiltration, a-SMA immunoreactivity in the interstitium,
and the expression levels of TGF-b1, PDGF-A, IGF1, Agtr1 1/1 , 18.3 6 2.7%; macrophage infiltration in the
cortex: Agtr1 2/2, 99.9 6 9.6; Agtr1 1/1 , 97.8 6 8.5/there is no quantitatively appreciable difference between
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4003 field; in the medulla: Agtr1 2/2, 105.5 6 6.7; Agtr1 reason, we chose P16 for creating UUO in wild-type
mice and P21 for analyzing these various parameters in1/1 , 83.8 6 8.6/4003 field; a-SMA in the cortex: Agtr1
2/2, 1.03 6 0.05; Agtr1 1/1 , 1.23 6 0.05/4003 field; the kidneys.
These analyses revealed that the nature of the struc-in the medulla: Agtr1 2/2, 1.58 6 0.1, Agtr1 1/1 , 1.31 6
0.08/4003 field; TGF-b1 expression, Agtr1 2/2, 3.8 6 tural anomalies in mutant kidneys are qualitatively indis-
tinguishable from wild-type kidneys with obstruction cre-0.3; Agtr1 1/1 , 4.5 6 0.3; PDGF-A expression: Agtr1
2/2, 3.2 6 0.3; Agtr1 1/1 , 2.8 6 0.3; IGF1 expression: ated experimentally by ureteral ligation. Thus, in both
the mutant and artificially obstructed wild-type kidneys,Agtr1 2/2, 2.2 6 0.2; Agtr1 1/1 , 1.9 6 0.2; EGF expres-
sion: Agtr1 2/2, 0.25 6 0.06; Agtr1 1/1 , 0.33 6 0.07; the calyx is enlarged, whereas the papilla is atrophic, and
tubulointerstitial cells are not only abnormally apoptoticFigs. 2–6).
Among the parameters tested, only the level of EGF but also proliferative. Both are also characterized by
interstitial macrophage infiltration and fibrosis, andexpression was significantly lower in Agtr1 2/2 with
UUO (2.4 6 0.4) than in Agtr1 1/1 with UUO (4.3 6 within the local fibrotic area, TGF-b1, PDGF-A, and
IGF-1 are up-regulated, whereas EGF is down-regulated0.5, P , 0.05; Fig. 5).
as determined by both Northern blot analysis and histo-
Examination of wild-type kidneys with logical examination. All of these changes documented
pharmacological angiotensin-converting enzyme in this study are identical to those in rats with five day
inhibition after birth UUO [21, 26229]. Of interest, TGF-b1 mRNA expres-
sion was reported to be down-regulated in neonatal ratWe next examined the kidneys of neonatal wild-type
mice that had been given ACE inhibitor in order to kidneys subjected to ACE inhibition [30], whereas the
same parameter was found up-regulated in the mutantascertain that the anomalous kidney development re-
ported under this condition [5, 6] is also attributable to mice lacking type 1 receptor (Agtr1 2/2) or angioten-
sinogen (Agt 2/2) [7].those mechanisms currently investigated for Agtr1 2/2
Overall, a close similarity was found to exist in thismice. As shown in Figure 7, the morphology of the upper
study between Agtr1 2/2 kidneys and experimentallyurinary tract is markedly distorted in wild-type kidneys
obstructed wild-type kidneys; however, the mutant kid-subjected to pharmacological ACE inhibition (ACEI).
neys have some distinctive features that are not presentSimilar to Agtr1 2/2 kidneys, the ampulla-shaped pelvis
in the obstructed wild-type kidneys. Thus, mutant kidneysis absent in these mice at 21 days of age. Moreover,
carry renal vascular hypertrophy, whereas these vascularthe renal parenchymal damages are characterized by
changes are absent in the wild-type kidneys with UUOatrophic papilla with dilated calyx, increased BrdU incor-
at 21 days old and even in neonatal kidneys subjectedporation, apoptotic activity, macrophage infiltration, and
to surgical UUO (data not shown). In addition, in situa-SMA expression in the interstitium (Fig. 7). In addi-
hybridization for PDGF-A mRNA revealed that distinc-tion, in neonatal mice subjected to ACE inhibition for
tive positive signals are present in the papillary regionfive days, BrdU incorporation within the pelvic smooth
in wild-type mice, regardless of the presence or absencemuscle is significantly less in number than that in the
of ureteral ligation, whereas mutant kidneys lack thecontrol mice (control, 16.2 6 0.8%, N 5 5; ACEI 10.3 6
expression of PDGF-A mRNA in this area (Fig. 6) [7].0.9%, N 5 5, P , 0.001; Fig. 7), whereas renal parenchy-
These differences indicate the concurrent presence ofmal damages, specifically hypoplastic papilla and dilated
other pathophysiological processes unique to Agtr1 2/2calyx, were not evident at this time (data not shown).
kidneys. With these exceptions, all of the parameters
measured and described earlier here in Agtr1 2/2 kid-
DISCUSSION neys are qualitatively identical to those in Agtr1 1/1
Our study began with the comparison between Agtr1 with surgically induced complete UUO. In the next set
2/2 kidneys without surgical obstruction and wild-type of experiments, we examined whether the quantitative
kidneys with surgical complete UUO with respects to differences that exist between these two kidneys are at-
morphometrical, immunohistochemical, and molecular tributed to the degree of completeness of urinary tract
indices. In an earlier pilot study, although the expression obstruction, as that of Agtr1 2/2 is “partial,” whereas
of EGF mRNA was somewhat lower in Agtr1 2/2 kid- that of the wild type is complete. For this purpose, we
neys when compared with unmanipulated wild-type kid- surgically induced a complete UUO in Agtr1 2/2 and
neys, there was no appreciable abnormality in other duplicated the previously described measurements. The-
parameters, for example, gross morphology, BrdU incor- oretically, for the same purpose, one may consider a
poration, apoptotic activity, and the expression patterns removal of “presumed obstruction” in Agtr1 2/2 mice
of the TGF-b1, PDGF-A, and IGF1 mRNA in Agtr1 by surgically creating a vent along the upper urinary
2/2 kidneys at postnatal day 16 (P16). However, differ- tract. This approach is not feasible because we found
that nephrostomy closes spontaneously shortly after sur-ences became evident at postnatal day 21 (P21). For this
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Fig. 7. Pelvic smooth muscle proliferation, renal pelvis morphology,
kidney morphology, and quantitative analyses for proliferating cells,
apoptotic cells, macrophage infiltration, and a-SMA expression in renal
parenchyma of wild-type mice with neonatal ACE inhibition. (A) BrdU
incorporation is shown at the root portion of the renal pelvis at the age
of five days. In pups with vehicle treatment, BrdU-positive nuclei are
observed in great abundance in the smooth muscle layer. In pups with
ACE inhibition, however, there are few BrdU-positive nuclei in the
smooth muscle layer along the pelvis. Arrows indicate BrdU-positive
nuclei in the smooth muscle layer. (B) This represents gross appearances
of the renal pelvis from 21-day-old mice. The distinctive structure of
renal pelvis is absent in mice with neonatal ACE inhibition. (C) Coronal
sections of kidneys are shown. Mice with ACE inhibition have a hypo-
plastic papilla and a thin medulla, with a widening caliceal space. (D)
Quantitative analyses for proliferating cells (BrdU-positive nuclei),
apoptotic cells (TUNEL-positive cells), macrophage (F4/80-positive
cells) infiltration, and a-SMA expression in renal parenchyma of 21-
day-old mice with vehicle or ACE inhibitor treatment. In ACE inhibi-
tor-treated mice, all of these indices are higher in number than those
in control mice. Symbols are: (h) the cortex; (j) the medulla. Values
are expressed as mean 6 se (*P , 0.01 vs. control mice).
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gery in part because of the lack of constant peristaltic ments in urine concentrating ability [9, 12], are common
to humans and animals with mild urinary tract obstruc-movement of flow through the nephrostomy. Because,
in Agtr1 2/2 mice, lack of peristalsis prevails along the tion [34236]. These same functional abnormalities were
documented in earlier studies in rats given ACE inhibitorentire length of the urinary tract, it is expected that
complete removal of the “presumed obstruction” is not during the neonatal period [5, 6].
Angiotensinogen- [7–9] and ACE- [10212] deficientpossible experimentally.
The chronic ischemic process, for instance, is expected mice also have renal lesions similar to Agtr1 2/2 mice,
including hypoplastic papilla with widening of calicealto involve renal parenchymal damage, for example, tu-
bule cell proliferation and apoptosis, interstitial inflam- space, tubular dilation and atrophy, and interstitial fi-
brosis [13]. It has been speculated, from these observa-mation and fibrosis, up-regulation of TGF-b1, and/or
down-regulation of EGF during tissue remodeling [31]. tions, that angiotensin II promotes tubulogenesis directly
or regulates the expression of renal growth factor withinWhen a complete UUO was created in mutant kidneys,
the abnormal values in these kidneys became virtually these areas. In mice, however, no appreciable angioten-
identical quantitatively to those in wild-type kidneys with sin binding site is observed in the papilla and medulla
the same complete UUO; that is, mutant kidneys are [4, 37], nor is receptor gene promoter activity identified
not more severely affected. The difference in the level in these areas [13]. Moreover, BrdU incorporation in
of EGF mRNA expression that was present between the tubule cells in the medulla is rather higher in Agtr1
mutant kidneys and nonobstructed wild-type kidneys at 2/2 mice than that in wild-type mice. The renal injury
the age of 16 days continued to be present after five-day seen in these mice therefore appears to reflect an indirect
complete UUO in both kidneys. Collectively, based on effect of the inhibition of AT1 function on the renal
these qualitative and quantitative analyses, the dilated parenchyma.
calyx and atrophic papilla characterizing the kidney of We expanded this conclusion to the similar lesions that
Agtr1 2/2 shortly after birth are attributed primarily to develop after ACE inhibitor administration in growing
processes that are obstructive in nature. animals [5, 6], as the observations were duplicated in
In addition to the morphological evidence just dis- wild-type mice that were given an ACE inhibitor since
cussed, we have obtained functional evidence in this shortly after birth. As shown in Figure 7, in mice given
study that the urinary tract of Agtr1 2/2 mice is ob- ACE inhibitor after birth, the renal pelvis does not de-
structed. We measured the pelvic pressure and the down- velop properly, and this defect is followed by renal paren-
stream ureteral pressure in the same mice by using the chymal damage, a pattern identical to those in Agtr1 2/2
micropuncture servo-nulling method [19]. Although the or Agt 2/2 mice [4]. The renal abnormalities seen in
values for pelvic and ureteral pressure vary somewhat these rats and mice therefore are also attributed largely
among mice in each group, presumably reflecting the to urinary tract obstruction caused by the lack of the
characteristic wide variability in urine flow rate among renal pelvis and urinary peristalsis.
individual animals [32], the baseline pressure is always In summary, the kidney of neonatal rodents with de-
lower in the pelvis than in the distal ureter in the wild fective renin-angiotensin system carries functional and
type, whereas this negative pressure gradient is reversed structural abnormalities characteristic for obstructed
in mutants. This reversed pressure relationship between kidneys. This study also revealed that animals that are
the pelvis and ureter pressure is taken as evidence for completely deficient of this system from early embryonic
obstruction in rodents [32]. Because there is no identifi- stages carry renal vascular anomalies, which cannot be
able structural obstruction along the entire urinary tract reproduced by experimental urinary tract obstruction.
in Agtr1 2/2 mice, this reversed pressure relationship
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The patterns of functional abnormalities seen in mice
with a defective renin-angiotensin system also duplicate
APPENDIXthose of animals with partial anatomical obstruction in
the urinary tract. Both mild reductions in renal plasma ACE, angiotensin converting enzyme; ACEI, ACE inhibitor; Agtr1
2/2, homozygote for null mutations in both the angiotensin type 1 Aflow rate and glomerular filtration rate, as well as impair-
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